Livzon Syntpharm Co.,Ltd., a wholly-owned subsidiary of Livzon Pharmaceutical Group Inc., was established in September 1993 with a registered capital of 128.28 million yuan, located in zhuhai bonded zone, guangdong province. The company has a fixed asset investment of over 300 million yuan, an area of 100,000 square meters, an annual output value and sales volume of more than 600 million yuan, and has become one of the largest cephalosporin sterile API production bases in China. The main products are ceftriaxone sodium, cefuroxime sodium, cefdizine sodium, eprazole, ferulic acid sodium and so on. The company has three hundred-ton production lines, five hundred-ton production lines and two multi-functional pilot workshops. With an annual capacity of 600 tons of API and a production capacity of nearly 1,000 tons.
The company has about 500 employees, more than 120 scientific and technological personnel. It has established "industry-university-research" cooperative relations with Hong Kong polytechnic university, sun yat-sen university, Beijing institute of technology and other famous domestic and foreign scientific research institutions. The company adheres to the spirit of "standardization and innovation", takes technological innovation as the leading role, and insists on marketing and management innovation. Ceftriaxone sodium products won the title of "provincial quality products" and "provincial famous brand products"; Iprazole won the first prize of guangdong provincial science and technology progress award and the second prize of national science and technology progress award. The company is rated as guangdong high-tech enterprises, zhuhai advanced technology enterprises.